Factor V G1691A, Prothrombin G20210A, and Methylenetetrahydrofolate Reductase [MTHFR] C677T Gene Polymorphism in Angiographically Documented Coronary Artery Disease

被引:0
作者
Wassim Y. Almawi
Ghada Ameen
Hala Tamim
Ramzi R. Finan
Noha Irani-Hakime
机构
[1] Arabian Gulf University,Department of Medicine
[2] American University of Beirut,Department of Epidemiology and Biostatistics
[3] St. Georges-Orthodox Hospital,Department of Obstetrics and Gynecology
来源
Journal of Thrombosis and Thrombolysis | 2004年 / 17卷
关键词
coronary artery disease; MTHFR; mutations; coagulation factors;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Single point mutations in the genes coding for factor V [G1691A; Leiden], prothrombin [PRT; G20210A], and methylenetetrahydrofolate reductase [MTHFR, C677T] were shown to be major inherited predisposing factors for venous thromboembolism. However, their contribution in the development of coronary artery disease [CAD] remains controversial. The aim of the study was to examine the association of these mutations in CAD.
引用
收藏
页码:199 / 205
页数:6
相关论文
共 153 条
  • [1] Crouse JR(2002)Associations of extracranial carotid atheroscle-rosis progression with coronary status and risk factors in patients with and without coronary artery disease Circulation 106 2061-2066
  • [2] Tang R(2002)Hyperhomo-cyst[ e]inemia and hemostatic factors: The atherosclerosis risk in communities study Ann Epidemiol 12 228-236
  • [3] Espeland MA(2000)Hemostatic ab-normalities in patients with congestive heart failure: Diagnostic significance and clinical challenge Int J Cardiol 75 15-21
  • [4] Terry JG(2001)Hemostatic risk factors for atherothrom-botic disease: An epidemiologic view Thromb Haemost 86 366-373
  • [5] Morgan T(1999)Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males Blood 93 2186-2190
  • [6] Mercuri M.(2001)Contribution of pro-thrombin 2021 0A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemo-static deficiencies Haematologica 86 1200-1208
  • [7] Schreiner PJ(2001)Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism Thromb Res 104 317-324
  • [8] Wu KK(1994)Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 64-67
  • [9] Malinow MR(1999)Cleavage of factor V atArg 506 by activated protein C and the expression of anticoagulant activity of factor V Blood 93 2552-2558
  • [10] Davis CJ(1997)Regulation of thrombin formation by activated protein C: Effect of the factor V Leiden mutation Semin Hematol 34 244-255